Trial intelligence / Profile preview

Feasibility study of post-meal administration of Myrtol Standardized Enteric Capsules

ChiCTR-IPR-15005849Phase 4Completed

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of myrtol, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Oral absorption and bioavailability. Started Jun 2013; status: completed.

02

Drugs

myrtol

Beyond the preview

Go deeper on ChiCTR-IPR-15005849.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15005849.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call